What's New
Forgot Password
New Users
Corporate Info
IPO
News
Other Markets
MF Schemes
MF Trends
MF Buzz
MF Tools
Knowledge
MF Disclosure
Insurance
Reports
Tools
BSE
Quotes
MARKET ANALYSIS
NEWS
CORPORATE INFORMATION
CORPORATE ACTIONS
OTHER MARKETS
Gainers & Losers
Live Indices
Index Movers
Value & Volume Toppers
Advances & Declines
Only Buyers/Sellers
Bulk Deals
Block Deals
Sector Watch
New Highs & Lows
52 Week Highs & Lows
Out/Under Performers
Index Constituents
Unusual Volume
Historical Returns
Exchange Holidays
Pre-Session
Mid-Session
End-Session
Quick Peek
Market Beat
Stock Alert
Corporate Results
Foreign Markets
Economy News
Corporate News
Other Markets
Futures Market
Analyst Poll
Hot Pursuit
Business News
MutualFund News
IPO News
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Quarterly Result
Balance Sheet
Financial Ratios
Share Price
Director's Report
Score Board
MF Holdings
Share Holding Pattern
Name Change
Price Chart
Share Price Analysis
Company News
Peer Comparison
Interactive Chart
BSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change of Name
Split Of Face Value
ADR Prices
FII Investment
MF Investment
Forex
World Indices
Your Result on :
Company News
Divis Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (
R
s
)
629.4942217
NSE Symbol
DIVISLAB
Divident Yield %
0.3
Market Cap
(
R
s
In Cr.)
264,141
P/E (TTM)
88.17
EPS (TTM)
112.85
Face Value
(
R
s
)
2
Date
Heading
30-Oct-26
Divis Laboratories Ltd spurts 1.52%, up for fifth straight session
28-Oct-26
Divis Laboratories Ltd soars 1.17%, rises for third straight session
23-Oct-26
Divis Laboratories to announce Quarterly Result
05-Oct-26
Divis Laboratories Ltd slips for fifth straight session
16-Sep-26
Divis Laboratories Ltd down for fifth straight session
03-Aug-26
Divi's Lab gains as Q1 PAT climbs 66% YoY to Rs 902 crore
01-Aug-26
Divi's Laboratories consolidated net profit rises 65.50% in the June 2
01-Aug-26
Divi's Lab Q1 PAT climbs 66% YoY to Rs 902 crore
31-Jul-26
Divis Laboratories announces change in senior management
31-Jul-26
Divis Laboratories Ltd spurts 2.48%, rises for fifth straight session
29-Jul-26
Divis Laboratories Ltd gains for third consecutive session
20-Jul-26
Divis Laboratories announces board meeting date
15-Jul-26
Divis Laboratories Ltd spurts 1.5%, up for five straight sessions
03-Jun-26
Volumes jump at Concord Biotech Ltd counter
25-May-26
Divis Laboratories schedules AGM
PREV |
NEXT
Risk Factor
|
Terms & Conditions
|
Privacy Policy
|
Disclaimer
|
Sitemap
Important Links:
SEBI
|
NSE
|
BSE
|
MCX
|
NCDEX
|
NSDL
|
CDSL
|
FMC
BSE Delayed market data sourced at 5 minutes –
www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved.
Designed, Developed , Maintained and Content Powered by
CMOTS InfoTech
(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)